Introducing 

Prezi AI.

Your new presentation assistant.

Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.

Loading…
Transcript

Conclusion

Was the study presented clearly?

  • yes, but I did have to use an other source to help support the information the author was giving because it was vague.

The author's conclusion and future experiments:

  • It concludes that the therapy isn't "one size fits all", but this therapy does show promise for at least some of the neuromuscular disorders.
  • Researches plan on continuing their work by looking into other neuromuscular diseases in mice to see which ones this gene therapy will help.

Why did I choose this article?

  • Millions of people are affected by neuromuscular disorders and about 40% of them are under the age of 18
  • No one should have to live with this.

Results

  • After just seven weeks the mice that had other neuromuscular disorders gained weight and their muscles grew stronger.

  • The mice with defective DOK7 genes were severely underweight and died at a young age.

  • For the mice with EDMD the size of the NMJs increased compared to the mice with EDMD that were not treated.

  • Unfortunately, the mice with EDMD did not fully recover like the mice with other disorders did.

The Study

  • A team of researchers from the University of Tokyo, led by molecular biologist Yuji Yamanashi, engineered a virus to contain a effective normal human DOK7 gene.

  • Researches injected the virus into mice with the two neuromuscular diseases, which shuttled the gene into the cells.

  • Researchers began to try their experimental virus on mice with EDMD.

Background Information

  • Muscular Dystrophy- a disease that creates muscle loss and over time becomes a lot worse.
  • Amyotrophic Lateral Sclerosis (ALS)- a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement.
  • Neuromuscular Junction (NMJ)- interface between neurons and muscle fibers.
  • DOK7- is a protein used for the proper formation of NMJ.

MAIN QUESTION:

  • Will a virus coded with effective DOK7 protein help improve muscles in subjects with certain neuromuscular disorders?
  • Will DOK7 gene therapy help patients with different muscular diseases such as Emery-Dreifuss Muscular Dystrophy (EDMD)?

Gene Therapy Helps Weak Mice Grow Strong

By: Jocelyn Kaiser

Source: news.sciencemag.org

Learn more about creating dynamic, engaging presentations with Prezi